UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 368

Sortiert nach

Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis

Oncogene, 2015-05, Vol.34 (21), p.2690-2699

2015

Volltextzugriff (PDF)

In Situ Molecular Profiling of Breast Cancer Biomarkers with Multicolor Quantum Dots

Advanced materials (Weinheim), 2007-10, Vol.19 (20), p.3146-3151

2007

Volltextzugriff (PDF)

Interim Analysis of a Phase I Study of Veliparib With Gemcitabine and IMRT in Patients With Borderline and Locally Advanced Unresectable Pancreatic Cancer

International journal of radiation oncology, biology, physics, 2015-11, Vol.93 (3), p.E181-E181

2015

Volltextzugriff (PDF)

A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies

British journal of cancer, 2013-03, Vol.108 (4), p.762-765

2013

Volltextzugriff (PDF)

Efficacy of Esomeprazole for Treatment of Poorly Controlled Asthma

The New England journal of medicine, 2009-04, Vol.360 (15), p.1487-1499

2009

Volltextzugriff (PDF)

Critical evaluation of the Hirschsprung-associated enterocolitis (HAEC) score: A multicenter study of 116 children with Hirschsprung disease

Journal of pediatric surgery, 2018-04, Vol.53 (4), p.708-717

2018

Volltextzugriff (PDF)

Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial

BMC pulmonary medicine, 2022-12, Vol.22 (1), p.475-13, Article 475

2022

Volltextzugriff (PDF)

Phase II trial of pembrolizumab with cisplatin and gemcitabine in women with recurrent platinum-resistant ovarian cancer

Gynecologic oncology, 2019-06, Vol.154, p.16-17

2019

Volltextzugriff (PDF)

UGT1A7 and UGT1A9 Polymorphisms Predict Response and Toxicity in Colorectal Cancer Patients Treated with Capecitabine/Irinotecan

Clinical cancer research, 2005-02, Vol.11 (3), p.1226-1236

2005

Volltextzugriff (PDF)

International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity

Blood, 1989-02, Vol.73 (2), p.391-396

1989

Volltextzugriff (PDF)

Biocidal Activity of Benzothiazole and Arylaminomalonate Derivatives

Russian journal of general chemistry, 2017-12, Vol.87 (13), p.3255-3258

2017

Volltextzugriff (PDF)

Phase II trial of dolastatin-10, a novel anti-tubulin agent, in metastatic soft tissue sarcomas

Sarcoma, 2004-12, Vol.2004 (4), p.107-111

2004

Volltextzugriff (PDF)

Cancer phase I clinical trials: efficient dose escalation with overdose control

Statistics in medicine, 1998-05, Vol.17 (10), p.1103-1120

1998

Volltextzugriff (PDF)

Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model

Cancer research (Chicago, Ill.), 2002-08, Vol.62 (16), p.4767-4772

2002

Volltextzugriff (PDF)

Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipients

Bone marrow transplantation (Basingstoke), 2004-01, Vol.33 (1), p.71-78

2004

Volltextzugriff (PDF)

International Fanconi Anemia Registry: Relation of Clinical Symptoms to Diepoxybutane Sensitivity

Blood, 1989-02, Vol.73 (2), p.391-396

1989

Volltextzugriff (PDF)

Obesity in children with poorly controlled asthma: Sex differences

Pediatric pulmonology, 2013-09, Vol.48 (9), p.847-856

2013

Volltextzugriff (PDF)

Effects of Asymptomatic Proximal and Distal Gastroesophageal Reflux on Asthma Severity

American journal of respiratory and critical care medicine, 2009-11, Vol.180 (9), p.809-816

2009

Volltextzugriff (PDF)

Patient Characteristics Compete with Dose as Predictors of Acute Treatment Toxicity in Early Phase Clinical Trials

Clinical cancer research, 2004-07, Vol.10 (14), p.4645-4651

2004

Volltextzugriff (PDF)

Optimal Bayesian-feasible dose escalation for cancer phase I trials

Statistics & probability letters, 1998-06, Vol.38 (3), p.215-220

1998

Volltextzugriff (PDF)

Phase II and Pharmacodynamic Study of the Farnesyltransferase Inhibitor R115777 as Initial Therapy in Patients With Metastatic Pancreatic Adenocarcinoma

Journal of clinical oncology, 2003-04, Vol.21 (7), p.1301-1306

2003

Volltextzugriff (PDF)

Phase I Trial of Multiple Cycles of High-Dose Carboplatin, Paclitaxel, and Topotecan With Peripheral-Blood Stem-Cell Support as Front-Line Therapy

Journal of clinical oncology, 2001-02, Vol.19 (4), p.1183-1194

2001

Volltextzugriff (PDF)

Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane‐refractory/resistant nonsmall cell lung carcinoma

Cancer, 2005-08, Vol.104 (3), p.561-569

2005

Volltextzugriff (PDF)

Phase II Studies: Which Is Worse, False Positive or False Negative?

JNCI : Journal of the National Cancer Institute, 1996-04, Vol.88 (7), p.462-462

1996

Volltextzugriff (PDF)

The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma

Clinical cancer research, 2001-05, Vol.7 (5), p.1181-1191

2001

Volltextzugriff (PDF)

1 – 25 von 368

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(291)
Mit Volltextzugriff
(337)

Publikationsform

Sprache

Englisch
(362)
Japanisch
(27)
Polnisch
(10)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(2)

Menü

Weitere Dienste

Einstellungen

Stromal fibroblast-derived miR-409 promotes epithelial-to-mesenchymal transition and prostate tumorigenesis

In Situ Molecular Profiling of Breast Cancer Biomarkers with Multicolor Quantum Dots

Interim Analysis of a Phase I Study of Veliparib With Gemcitabine and IMRT in Patients With Borderline and Locally Advanced Unresectable Pancreatic Cancer

A phase 1 Bayesian dose selection study of bortezomib and sunitinib in patients with refractory solid tumor malignancies

Efficacy of Esomeprazole for Treatment of Poorly Controlled Asthma

Critical evaluation of the Hirschsprung-associated enterocolitis (HAEC) score: A multicenter study of 116 children with Hirschsprung disease

Design and rationale for the prospective treatment efficacy in IPF using genotype for NAC selection (PRECISIONS) clinical trial

Phase II trial of pembrolizumab with cisplatin and gemcitabine in women with recurrent platinum-resistant ovarian cancer

UGT1A7 and UGT1A9 Polymorphisms Predict Response and Toxicity in Colorectal Cancer Patients Treated with Capecitabine/Irinotecan

International Fanconi Anemia Registry: relation of clinical symptoms to diepoxybutane sensitivity

Biocidal Activity of Benzothiazole and Arylaminomalonate Derivatives

Phase II trial of dolastatin-10, a novel anti-tubulin agent, in metastatic soft tissue sarcomas

Cancer phase I clinical trials: efficient dose escalation with overdose control

Promotion of tumor growth by murine fibroblast activation protein, a serine protease, in an animal model

Measurable immune dysfunction and telomere attrition in long-term allogeneic transplant recipients

International Fanconi Anemia Registry: Relation of Clinical Symptoms to Diepoxybutane Sensitivity

Obesity in children with poorly controlled asthma: Sex differences

Effects of Asymptomatic Proximal and Distal Gastroesophageal Reflux on Asthma Severity

Patient Characteristics Compete with Dose as Predictors of Acute Treatment Toxicity in Early Phase Clinical Trials

Optimal Bayesian-feasible dose escalation for cancer phase I trials

Phase II and Pharmacodynamic Study of the Farnesyltransferase Inhibitor R115777 as Initial Therapy in Patients With Metastatic Pancreatic Adenocarcinoma

Phase I Trial of Multiple Cycles of High-Dose Carboplatin, Paclitaxel, and Topotecan With Peripheral-Blood Stem-Cell Support as Front-Line Therapy

Phase II study of the farnesyltransferase inhibitor lonafarnib with paclitaxel in patients with taxane‐refractory/resistant nonsmall cell lung carcinoma

Phase II Studies: Which Is Worse, False Positive or False Negative?

The Influence of Granulocyte Macrophage Colony-Stimulating Factor and Prior Chemotherapy on the Immunological Response to a Vaccine (ALVAC-CEA B7.1) in Patients with Metastatic Carcinoma

Suchergebnisse filtern